Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
NCT04922424
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
not funded
Conditions
Hypertension
Hyperlipidemias
Interventions
DRUG:
Atorvastatin
OTHER:
placebo
Sponsor
Yale University